TY - JOUR
T1 - One-year follow-up results of the 1985-1986 National Heart, Lung, and Blood Institute's Percutaneous Transluminal Coronary Angioplasty Registry
AU - Detre, K.
AU - Holubkov, R.
AU - Kelsey, S.
AU - Bourassa, M.
AU - Williams, D.
AU - Holmes, D.
AU - Dorros, G.
AU - Faxon, D.
AU - Myler, R.
AU - Kent, K.
AU - Cowley, M.
AU - Cannon, R.
AU - Robertson, T.
N1 - Funding Information:
Financial Support: This work was supported by the National Heart, Lung, and Blood Institute (Contracts HHSN268201500003I, N01-HC-95159, N01-HC-95160, N01-HC-95161, N01-HC-95162, N01-HC-95163, N01-HC-95164, N01-HC-95165, N01-HC-95166, N01-HC-95167, N01-HC-95168, and N01-HC-95169), the National Center for Advancing Translational Sciences (Grant UL1-TR-000040, Grant UL1-TR-001079, and Grant UL1-TR-001420), and the National Institute of Diabetes and Digestive and Kidney Diseases (Grant R01DK088762), (Grant R01DK099199), and Grant (K01DK109019).
PY - 1989
Y1 - 1989
N2 - In 1,801 patients in the 1985-1986 Percutaneous Transluminal Coronary Angioplasty Registry, overall 1-year mortality was 3.2%, the 1-year myocardial infarction rate was 7.2%, and the 1-year coronary artery bypass surgery rate was 13.2%. In the 78% of the cohort with all lesions successfully dilated and without major procedural complications (successful patients), the corresponding rates were 1.9%, 2.6%, and 6.4%. Nearly 20% of all deaths, 40% of all infarctions, and 25% of all bypass operations occurred in the small subset of patients (6.8%) who sustained periprocedural occlusion. Event rates were higher in patients with multivessel disease than in those with one-vessel disease. At 1 year, angina-free status was reported by approximately three fourths of all surviving patients, regardless of initial success. However, compared with successful patients, unsuccessful patients underwent intervening bypass surgery (42% vs. 6%) to achieve asymptomatic status more frequently. Comparison of the 1-year event rates in the 1985-1986 registry with those in the 1977-1981 registry indicated reductions in all major untoward events. These reductions became apparent after controlling for the more extensive disease of the 1985-1986 registry patients. In contrast, use of repeat angioplasty has increased by 50%. We conclude that the improved initial results reported in the 1985-1986 registry cohort were maintained at 1-year follow-up.
AB - In 1,801 patients in the 1985-1986 Percutaneous Transluminal Coronary Angioplasty Registry, overall 1-year mortality was 3.2%, the 1-year myocardial infarction rate was 7.2%, and the 1-year coronary artery bypass surgery rate was 13.2%. In the 78% of the cohort with all lesions successfully dilated and without major procedural complications (successful patients), the corresponding rates were 1.9%, 2.6%, and 6.4%. Nearly 20% of all deaths, 40% of all infarctions, and 25% of all bypass operations occurred in the small subset of patients (6.8%) who sustained periprocedural occlusion. Event rates were higher in patients with multivessel disease than in those with one-vessel disease. At 1 year, angina-free status was reported by approximately three fourths of all surviving patients, regardless of initial success. However, compared with successful patients, unsuccessful patients underwent intervening bypass surgery (42% vs. 6%) to achieve asymptomatic status more frequently. Comparison of the 1-year event rates in the 1985-1986 registry with those in the 1977-1981 registry indicated reductions in all major untoward events. These reductions became apparent after controlling for the more extensive disease of the 1985-1986 registry patients. In contrast, use of repeat angioplasty has increased by 50%. We conclude that the improved initial results reported in the 1985-1986 registry cohort were maintained at 1-year follow-up.
UR - http://www.scopus.com/inward/record.url?scp=0024432248&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024432248&partnerID=8YFLogxK
U2 - 10.1161/01.CIR.80.3.421
DO - 10.1161/01.CIR.80.3.421
M3 - Article
C2 - 2527641
AN - SCOPUS:0024432248
SN - 0009-7322
VL - 80
SP - 421
EP - 428
JO - Circulation
JF - Circulation
IS - 3
ER -